| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000229852.2 |
Gefitinib |
Breast invasive carcinoma |
0.009858436 |
Resistant |
| ENSG00000229852.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002730892 |
Resistant |
| ENSG00000229852.2 |
Gefitinib |
Esophageal cancer |
0.02969718 |
Sensitive |
